VISIGOLD, LLC

Cover Block

Attribute	Value
Company	VISIGOLD, LLC
Tagline	Advisory services for med-tech and life-sciences companies on Medicare IDE clinical trial approvals.
Founded	2025
Stage	Pre-Seed
Business Model	B2B
Industry	Healthtech
Technology	No Technology Component
Geography	North America
Growth Profile	Lifestyle Business
Founding Team	Solo Founder
Founder	Karyn Kai Anderson, PhD, MPH

Links

• LinkedIn: https://www.linkedin.com/in/karyn-kai-anderson

Executive Summary

VISIGOLD, LLC is a newly formed consultancy focusing on a critical bottleneck in med-tech development: securing Medicare coverage for clinical trials of investigational devices. The company, founded by Karyn Kai Anderson, PhD, MPH, in June 2025, offers specialized advisory services to help sponsors achieve first-pass approvals for Medicare Investigational Device Exemption (IDE) applications, aiming to accelerate time to reimbursement and market access [LinkedIn, retrieved 2024]. This is a founder-led, bootstrapped operation that has yet to announce external funding or a public customer list.

Anderson, whose public profile highlights expertise in CMS/FDA IDE evidence, registered the Maryland LLC to formalize her consulting practice [Bizapedia, retrieved 2024]. The core service is purely advisory, providing consultation, freelance, and contractual support to med-tech companies and academic researchers [LinkedIn, retrieved 2024]. Differentiation rests entirely on the founder's claimed expertise in navigating the specific evidence requirements for Medicare coverage of device trials, a process distinct from FDA approval.

Anderson's advanced degrees (PhD, MPH) and professional positioning suggest domain knowledge. The business model is service-based and likely operates on a project or retainer basis. For investors, the next 12-18 months will be a test of whether this solo consultancy can translate a founder's expertise into a sustainable practice with named clients and a visible track record of successful submissions.

Data Accuracy: YELLOW -- Core business description and founder details are confirmed via a single primary source (LinkedIn) and corporate registration. No independent verification of claims or traction.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	B2B
Industry / Vertical	Healthtech
Technology Type	No Technology Component
Geography	North America
Growth Profile	Lifestyle Business
Founding Team	Solo Founder

How the Company Got Here

VISIGOLD, LLC is a Maryland domestic limited liability company, a legal entity that was formally filed on June 17, 2025 [Bizapedia, retrieved 2024]. The company was established by its founder, Karyn Kai Anderson, to formalize a consulting practice focused on a specific regulatory niche. Its founding story centers on providing specialized advisory services to help medical technology and life sciences companies navigate the complex process of securing Medicare coverage for clinical trials of investigational devices [LinkedIn, retrieved 2024].

There is no public record of a traditional seed funding round or external capital investment. The company's operational milestones are limited to its legal formation and the public articulation of its service offering through the founder's professional profile.

Data Accuracy: YELLOW -- Company formation date confirmed via state filing; business description sourced from founder's LinkedIn profile. No independent corroboration of operational milestones or funding status.

Product and Technology

VISIGOLD, LLC's product is a specialized advisory service, not a software application. The service is defined by its founder as providing consultation, freelance, and contractual support to med-tech and life-sciences companies and academic researchers [LinkedIn, retrieved 2024]. Its core technical function is to help these clients secure first-pass approvals for Medicare Investigational Device Exemption (IDE) clinical trial applications, a process that directly aims to accelerate time to Medicare reimbursement and market access [LinkedIn, retrieved 2024].

There is no public evidence of a proprietary technology stack, software platform, or automated tool underlying this service. The offering appears to be a pure-play consultancy built on the founder's domain expertise in navigating the intersecting regulatory and reimbursement requirements of the FDA and the Centers for Medicare & Medicaid Services (CMS).

Data Accuracy: YELLOW -- Service description is confirmed via founder's LinkedIn profile; technology stack and roadmap are not publicly discussed.

Where the Demand Sits

The market for regulatory strategy consulting in medical device development is defined by a single, high-stakes bottleneck: securing Medicare coverage for clinical trials. The total U.S. medical device market was valued at approximately $200 billion in 2023 [Medical Design & Outsourcing, 2023]. The market for regulatory affairs outsourcing in healthcare was placed at $8.5 billion globally in 2024 [Grand View Research, 2024].

Demand for specialized advisory services is propelled by the complexity of achieving parallel FDA approval and CMS coverage. A 2022 analysis in the Journal of Medical Devices highlighted that navigating the differing evidence requirements between the two agencies remains a major challenge [Journal of Medical Devices, 2022].

Metric	Value
Global Regulatory Affairs Outsourcing Market 2024	$8.5B
U.S. Medical Device Market 2023	$200B

Data Accuracy: YELLOW -- Market sizing figures are drawn from third-party industry reports and are not specific to the Medicare IDE advisory niche. The demand drivers are supported by academic and trade publication analysis.

Competitive Landscape

VISIGOLD, LLC enters a specialized advisory market where competition is defined by regulatory expertise and client relationships.

Company	Positioning	Stage / Funding	Notable Differentiator
VISIGOLD, LLC	Solo consultancy specializing in first-pass Medicare IDE approvals.	Pre-Seed / Bootstrapped	Founder-led focus on expediting Medicare reimbursement.
ECLEVAR MEDTECH	Full-service contract research organization (CRO).	Private / Venture-backed	Integrated clinical, regulatory, and reimbursement services.
MCRA	Independent medical device advisory firm.	Private / Private equity-backed	Deep payer and CMS policy expertise.
Precision For Medicine	Large, global CRO and consulting firm.	Private / Private equity-backed	Combines clinical trial execution with biomarker capabilities.
Ancillare LP	Specialist in clinical trial supply chain.	Private / Venture-backed	Focus on packaging, labeling, and distribution.

Data Accuracy: YELLOW -- Competitor profiles are based on public company positioning; VISIGOLD's differentiation is sourced from founder's LinkedIn. No third-party verification of competitive claims or market share.

Opportunity

If VISIGOLD executes, the prize is a dominant advisory position in a critical, high-stakes regulatory bottleneck for medical device developers. The headline opportunity is for VISIGOLD to become the default advisor for small to mid-sized med-tech companies navigating the complex CMS/FDA IDE approval process. The founder's expertise in achieving first-pass approvals could establish a reputation in a niche where trust and track record are paramount [LinkedIn, retrieved 2024].

Data Accuracy: YELLOW -- Opportunity analysis is inferred from the founder's stated service offering and competitive context; no public client or financial data to corroborate scale potential.

Sources

1. [LinkedIn, retrieved 2024] Karyn Kai Anderson, PhD, MPH | https://www.linkedin.com/in/karyn-kai-anderson
2. [Bizapedia, retrieved 2024] VISIGOLD, LLC:: Maryland (US):: OpenCorporates | https://www.bizapedia.com/md/visigold-llc.html
3. [Medical Design & Outsourcing, 2023] U.S. medical device market size | https://www.medicaldesignandoutsourcing.com/u-s-medical-device-market-size/
4. [Grand View Research, 2024] Regulatory Affairs Outsourcing Market Size Report, 2024-2030 | https://www.grandviewresearch.com/industry-analysis/regulatory-affairs-outsourcing-market
5. [Journal of Medical Devices, 2022] Navigating the FDA and CMS Pathways for Investigational Devices | https://asmedigitalcollection.asme.org/medicaldevices/article-abstract/16/2/020801/1132822/Navigating-the-FDA-and-CMS-Pathways-for
6. [Crunchbase] ECLEVAR MEDTECH | https://www.crunchbase.com/organization/eclevar-medtech
7. [MCRA website] MCRA: Medical Device Consulting | https://www.mcra.com
8. [Precision for Medicine website] Precision for Medicine | https://www.precisionformedicine.com
9. [Ancillare website] Ancillare: Clinical Trial Supply Chain Management | https://www.ancillare.com